PXS.L Stock - Provexis plc
Unlock GoAI Insights for PXS.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.29M | $801,964 | $389,916 | $426,168 | $505,329 |
| Gross Profit | $532,940 | $283,795 | $294,419 | $380,049 | $456,193 |
| Gross Margin | 41.2% | 35.4% | 75.5% | 89.2% | 90.3% |
| Operating Income | $-448,319 | $-603,592 | $-420,927 | $-299,205 | $-361,916 |
| Net Income | $-452,720 | $-586,243 | $-385,241 | $-224,250 | $-341,007 |
| Net Margin | -35.0% | -73.1% | -98.8% | -52.6% | -67.5% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Visit WebsiteEarnings History & Surprises
PXS.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 29, 2025 | — | — | — | — |
Q4 2024 | Dec 27, 2024 | — | $-0.00 | — | — |
Q3 2024 | Sep 27, 2024 | — | $-0.00 | — | — |
Q4 2023 | Dec 29, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.00 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.00 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.00 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.00 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.00 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.00 | — | — |
Q3 2016 | Sep 30, 2016 | — | $-0.00 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.00 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about PXS.L
What is PXS.L's current stock price?
What is the analyst price target for PXS.L?
What sector is Provexis plc in?
What is PXS.L's market cap?
Does PXS.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PXS.L for comparison